Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Zollinger-Ellison Syndrome With Prevacid

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Zollinger-Ellison syndrome~Exclusion Criteria:~* Pregnant or lactating females

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- single group (Type: EXPERIMENTAL): This is an open label, non-randomized, uncontrolled, single group study designed to treat patients with Zollinger-Ellison Syndrome and other hypersecretory conditions by controlling gastric acid production; to heal and prevent relapses of peptic ulcers and symptoms; to monitor the safety and efficacy of this treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).